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Abstract: Integrins are transmembrane heterodimers that play a fundamental role in the 
migration of leukocytes to sites of infection or injury.  Here, we provide evidence that the protein 
tyrosine phosphatase PTPN22 is a novel regulator of LFA-1 signaling in effector T-cells.  
PTPN22 co-localizes with its substrates at the leading edge of cells migrating on ICAM-1.  Gene 
targeting, or expression of the autoimmune disease-associated PTPN22-R620W variant, results 
in hyper-phosphorylation of integrin signaling intermediates.  Super-resolution imaging reveals 
that in the steady state PTPN22-R620 exists in large clusters that disaggregate upon LFA-1 
stimulation, permitting increased association with its binding partners at the membrane. Failure 
to retain PTPN22-R620W molecules at the membrane leads to increased LFA-1 clustering and 
integrin-mediated cell adhesion.  Our data define a novel mechanism for fine-tuning integrin 
signaling in T-cells, and a new paradigm of autoimmunity in man in which disease susceptibility 
is underpinned by inherited perturbations of integrin function. 
 
One Sentence Summary: PTPN22 is a negative regulator of integrin signaling and loss-of-
function mutants increase cell adhesion. 
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Introduction 
Integrins function as adhesion receptors that control cell-cell and cell-matrix interactions, thereby 
regulating migration of cells into tissues. Lymphocyte Function-associated Antigen 1 (LFA-1; 
CD11a/CD18; L2) is the major integrin used by T-cells which, besides adhesion and 
migration, transduces environmental cues that impact on a wide range of cellular functions 
including cell differentiation, proliferation, cytokine production, cytotoxicity and cell survival 
(1-6). Optimal function requires changes in conformation and clustering of LFA-1 in ways that 
promote cell adherence, achieved through two distinct yet overlapping signaling pathways (7). 
Inside-out signaling is initiated by antigen or chemokine receptors, resulting in conformational 
changes in LFA-1 that increase the affinity of interactions with ligand, such as intercellular 
adhesion molecule (ICAM)-1, and binding of cytoplasmic signaling modules to integrin tails (8, 
9). Outside-in signaling is initiated following LFA-1 engagement with ICAM-1, and leads to Src 
and Syk-mediated protein tyrosine phosphorylation, membrane translocation of Rap1 and 
binding of talin and kindlin-3 to the cytoplasmic tail of the 2 subunit (10). While counter-
regulation of LFA-1 dependent protein tyrosine phosphorylation is required for repeated cycles 
of adhesion, de-adhesion, protrusion and contraction (11, 12), the protein tyrosine phosphatases 
that support this function are not well understood.  
 
PTPN22, known as Lyp in man and PEP in mouse, is a protein tyrosine phosphatase that 
dephosphorylates Src and Syk family kinases (13). Interest in PTPN22 has grown considerably 
since initial reports of strong associations between a missense single nucleotide polymorphism in 
the PTPN22 gene (1858C>T, encoding R620W) and a growing number of autoimmune diseases 
including type I diabetes, rheumatoid arthritis and systemic lupus erythematosus (14).  
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Functional studies have focused on how the phosphatase regulates antigen receptor signaling in 
lymphocytes, but precisely how the R620W variant confers susceptibility to autoimmune disease 
is unknown. Some studies have suggested that it is a loss-of-function mutation, while others 
point to gain-of-function (15, 16). Here, we investigated whether PTPN22 regulates LFA-1-
mediated signaling because its substrates, Lck and ZAP-70, are also phosphorylated following 
LFA-1 engagement (17, 18).  Our experiments were also motivated by the possibility that 
perturbations in integrin signal transduction might play a role in provoking immune-mediated 
inflammatory diseases in individuals carrying PTPN22 genetic polymorphism. 
 
Results 
PTPN22 co-localizes with its substrates at the leading edge of migrating T-cells 
To examine whether PTPN22 regulates outside-in integrin signaling, activated primary human T-
cells were plated onto ICAM-1 coated glass, prior to fixing, staining and imaging by confocal 
microscopy.  PTPN22 mainly polarized to the lamellipodium at the leading edge of migrating T-
cells (ICAM-1) with some staining in the uropod, while PTPN22 was not polarized in non-
migrating T-cells on glass coated with poly-L-lysine (PLL) (Fig. 1A). Specificity of staining was 
confirmed by gene knockdown, patterns of staining obtained with monoclonal and polyclonal 
antibodies to PTPN22, and by localization in PTPN22-GFP expressing T-cells (fig. S1A-C). 
Confocal microscopy and fluorescence intensity plots revealed phosphorylation of activatory 
tyrosine residues on Lck (pY394), ZAP-70 (pY493) and Vav (pY174) to be co-localized with 
PTPN22 at the leading edge of migrating cells (Fig. 1A and fig. S1D), but not non-migrating 
cells (fig. S1E). Analysis and quantification of Total Internal Reflection Fluorescence (TIRF) 
microscopy images confirmed membrane proximal associations between PTPN22 and 
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phosphorylated substrates at the leading edge of migrating T-cells, when compared to non-
migrating PLL controls (fig. S2A and B). 
 
Integrin signaling induces association between PTPN22 and its phosphorylated substrates 
Biochemical analysis of whole cell lysates confirmed inducible phosphorylation of integrin 
signaling intermediates in migrating T-cells in response to different integrin ligands (fig. S3A 
and B); specificity of the response was confirmed using soluble anti-ICAM-1 antibodies (fig. 
S3C). PTPN22 immunoprecipitates from non-migrating and migrating cells were then probed 
with an anti-phosphotyrosine antibody.  While a single phosphoprotein band was detected in 
non-migrating T-cells, many more phosphoproteins were detected in migrating T-cells, 
suggesting inducible association of PTPN22 with phosphotyrosine substrates (fig. S3D). Three 
of these bands resolved to molecular weights of phosphorylated Lck (56kD), ZAP-70 (70kD) and 
Vav (118kD). Their specificity and association with PTPN22 over time were confirmed by 
immunoblotting of anti-PTPN22 immunoprecipitates using anti-phosphospecific antibodies (Fig. 
1B). Importantly, PTPN22 associated only with phosphorylated protein substrates, as 
demonstrated by blotting for total proteins, indicating that phosphorylation was required for 
protein PTPN22-substrate interaction in migrating cells. 
  
PTPN22 is a negative regulator of integrin signaling; R620W is a loss-of-function mutant 
Targeting of PTPN22 with siRNA depleted protein expression in migrating T-cells by ~50-60%, 
without affecting LFA-1 expression (fig. S3E), but increased ICAM-1 induced phosphorylation 
of Lck(pY394), ZAP-70(pY493) and Vav(pY174) when compared to control siRNA in 
migrating cells (Fig. 1C).  Unlike pY493-ZAP-70, increased phosphorylation of the regulatory 
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Y319-ZAP-70, which is not a target of PTPN22 (13), was less pronounced. PTPN22 knockdown 
was also associated with increased cell motility (Fig. 1D), while overexpression of wild-type 
PTPN22-R620 in PTPN22 sufficient T-cells, but not a catalytically inactive C227A mutant or 
control vector, reduced cell motility (Fig. 1E). The phosphatase activity of PTPN22 was 
therefore required for regulation of integrin-mediated cell motility.  Integrin dependent 
phosphorylation of the classical mitogen activated protein kinase ERK1/2 (extracellular-signal-
regulated kinase) was also observed following LFA-1 engagement (Fig. 1C), consistent with its 
localization in nascent adhesion complexes and its contribution to the “motor phase” of 
lamellopodium protrusion (19-21).  This was blocked by the Lck inhibitor PP2 (fig. S3F), 
demonstrating that integrin-induced Lck activation is upstream of ERK phosphorylation, as 
previously reported (18). In keeping with these data, ERK was hyper-phosphorylated in 
migrating Ptpn22-/- deficient murine T-cells (Fig. 1F), and in human T-cells carrying either one 
or two copies of the PTPN22 genetic variant encoding PTPN22-W620 (Fig. 1G).  These data 
indicated that PTPN22 is a negative regulator of LFA-1 signaling, and suggested that the R620W 
variant is a loss-of-function mutant.  
 
PTPN22 and Csk localize in membrane proximal clusters that decluster during LFA-1 induced 
migration. 
Diffraction limited microscopy showed significant localization of PTPN22 at the leading edge of 
migrating T-cells following LFA-1 engagement (Fig. 1A). To obtain quantitative imaging data of 
this phenomenon at the membrane, TIRF-dSTORM super-resolution microscopy and quantitative 
cluster analysis was employed. These techniques quantify protein (localization) and cluster 
number, as well as cluster size and density of PTPN22 protein localization at the membrane of 
 7 
stationary cells or at leading edge of migrating T-cells. Visualization of single molecules can be 
represented by point maps and cluster heat maps. Using this approach, PTPN22 was found to be 
highly clustered at the plasma membrane of non-migrating T-cells (PLL), while analysis of 
migrating T-cells revealed smaller, less dense clusters (Fig. 2A), confirmed by quantitative 
cluster analysis (Fig. 2B and C). Quantification by Ripley’s K-function, a measure of clustered-
ness, also revealed a substantial reduction in clustering (peak of L(r)-r curve) and the presence of 
smaller clusters (position of the peak on the x-axis) at the leading edge (Fig. 2D), further 
confirming that PTPN22 was substantially less clustered in migrating T-cells. Csk also exhibited 
this declustering phenomenon upon LFA-1 stimulation (15% of localizations in clusters versus 
30% in non-migrating cells), although the heat maps revealed more cluster heterogeneity when 
compared to PTPN22 (fig. S4A-C). Concurrent with LFA-1 induced declustering of PTPN22 and 
Csk, we detected increased association between the phosphatase and kinase in both PTPN22 and 
Csk immunoprecipitates (fig. S4D and E), while the adaptor protein associated with glycolipid 
enriched microdomains (PAG, also known as Csk-binding protein), a binding partner of Csk (22), 
had notably less Csk and PTPN22 associated with it after ICAM-1 stimulation (fig. S4F and G).  
Consistent with these findings, tyrosine phosphorylation of PAG, known to regulate PAG and 
Csk binding (23), was also reduced upon LFA-1 engagement (fig. S4H). These data indicated that 
de-clustering of both PTPN22 and Csk coincides temporally with increased PTPN22-Csk 
complexing.   
 
Nanoscale organization of PTPN22-R620 and W620 clusters in migrating T-cells 
Closer examination of PTPN22-R620 localizations at the nanoscale level revealed that the 
transition from the non-migrating to the migrating state was associated with three cluster 
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characteristics.  Firstly, there was a modest reduction in the total number of clusters (Fig. 3A, 
closed symbols).  Secondly, PTPN22-R620 clusters become smaller.  This is based on a marked 
reduction in the % of PTPN22 localizations within clusters (Fig. 3B, closed symbols), a finding 
in keeping with the cluster heat maps, and the changes in diameter and density of clusters upon 
ICAM-1 stimulation (Fig. 2A-C).  Thirdly, there was a marked increase in the number of 
PTPN22-R620 localizations at the leading edge (Fig. 3C, closed symbols).  Thus, following 
LFA-1 stimulation PTPN22 molecules disperse from clusters, accumulating at the membrane in 
the vicinity of receptor proximal signaling intermediates.   
 
The cluster characteristics of the disease associated W620 mutant phosphatase were similar to 
the common R620 variant in non-migrating cells (Fig. 3D upper panel; compare open versus 
closed symbols for PLL in Fig. 3A-C).  In contrast, migrating T-cells expressing the PTPN22-
W620 variant had increased numbers and density of clusters (Fig. 3A and B, open symbols), 
evident in region point maps and heat maps (Fig. 3D lower panel). Indeed, the amplitude of 
Ripley’s K-function also suggested that PTPN22-W620 was more clustered (Fig. 3E).  
Unexpectedly, the total number of PTPN22-W620 molecules at the membrane was significantly 
reduced following LFA-1 stimulation, when compared to PTPN22-R620 (Fig. 3C, open versus 
closed symbols for ICAM-1).  This finding was in keeping with the point maps, showing reduced 
numbers of localizations outside of clusters (Fig. 3D lower panels, and fig. S5A), which could 
not be explained by differences in protein expression at the whole cell level (fig. S5B and C).  
 
By using simulated data to model the consequence of varying the density of the non-clustered 
background of molecules surrounding clusters we found that both linearity and the gradient of 
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Ripley’s K-function depend on the number of non-clustered localizations (fig. S5D and E). 
These simulations, together with the observed Ripley’s K-function data in Figure 3E, indicated 
that differences between PTPN22-R620 and W620 clustering were not due to changes in 
clustering behaviour of W620 per se, but a consequence of the lack of localizations outside of 
clusters, a finding in keeping with the pointillist maps (fig. S5A).  We surmised that declustered 
PTPN22-W620 molecules are not retained at the membrane in migrating T-cells to the same 
extent as R620. To explore the mechanism behind this difference in membrane localization we 
tested whether the P1 domain mutation in PTPN22-W620 compromised binding to SH3-domain 
protein partners, such as Csk, following integrin engagement. Csk immunoprecipitates were 
generated from homozygous donor-derived PTPN22-R620 or W620 expressing T-cells 
migrating on ICAM-1 and probed for PTPN22. The results clearly demonstrated a reduced level 
of Csk and PTPN22-W620 association in migrating T-cells compared to R620 (Fig. 3F). This 
suggests that upon LFA-1 stimulation, retention of PTPN22 at the membrane is dependent on the 
formation of a complex with Csk, or other SH3 domain containing proteins.  
 
PTPN22 associates with the LFA-1 signaling complex and regulates LFA-1 clustering 
LFA-1 mediated adhesion and migration of T-cells is regulated by conformational changes in the 
extracellular domain of the  and  chains, and physical clustering of heterodimers at the 
membrane (24-26).  Furthermore, Lck and ZAP-70 associate with the cytoplasmic tail of 
engaged LFA-1 (17, 27). Initial evidence for an association between LFA-1 and its regulator, 
PTPN22, derived from confocal images showing LFA-1 and PTPN22 co-localized at the leading 
edge (Fig. 4A). By TIRF microscopy, co-localization of LFA-1 and PTPN22 was also 
observed at the interface with ICAM-1 at the leading edge (Fig. 4B), returning a Manders’ co-
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localization coefficient (MCC) of 0.43 ± 0.14. This association was also supported by co-
immunoprecipitation experiments, in which LFA-1-PTPN22 interactions were observed to 
increase as a function of LFA-1 engagement (Fig. 4C). To address the mechanism for this 
association, we examined immunoprecipitates from the human leukemic Jurkat T-cell line and its 
Lck-deficient derivative JCaM1.6 (which expresses comparable levels of ZAP-70 and PTPN22 
to the parental cell line), and found that PTPN22 does not appear to complex with LFA-1 in the 
absence of Lck (Fig. 4D and fig. S6).  Thus, PTPN22 associates with the LFA-1 signaling 
complex in an Lck dependent manner, where it interacts with substrates to regulate integrin 
signaling.  
 
To examine the relationship between regulation of LFA-1 signaling by PTPN22 and LFA-1 
function, we first investigated how loss of PTPN22 function might impact LFA-1 clustering at 
the cell surface. Super-resolution TIRF-dSTORM maps showed increased clustering of LFA-1 at 
the leading edge of migrating T-cells expressing the W620 variant (Fig. 5A), corroborated by 
Ripley’s K-function (Fig. 5B). While there were no differences in the total number of LFA-1 
localizations, nor number of clusters (Fig. 5C and D), the percentage of LFA-1 molecules 
participating in clusters was increased in T-cells expressing the W620 variant (Fig. 5E). Thus, 
loss of PTPN22 function is associated with increased LFA-1 clustering at the leading edge of 
migrating T-cells.  
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Integrin-dependent adhesion is increased in T-cells expressing the loss-of-function PTPN22-
W620 variant  
In light of these findings we evaluated the functional consequences of enhanced LFA-1 
clustering by directly comparing the adhesion of R620 and W620 expressing T- cells under 
conditions of shear flow. T- cells expressing the disease-associated W620 variant were more 
adherent to ICAM-1 (Fig. 6A). Ptpn22 deficient murine T-cells phenocopied the disease-
associated variant, being more adherent under shear-flow (Fig. 6B), and more adherent in de-
attachment assays (Fig. 6C). Thus, loss-of-function PTPN22 mutants that enhance LFA-1 
signaling increase LFA-1 clustering and cell adhesion.  Taken together, our results indicate that 
in migrating T-cells, PTPN22 disperses from large membrane proximal clusters into smaller 
clusters capable of interacting with the LFA-1 adhesome where fine-tuning of signals can 
regulate integrin clustering and adhesion. If PTPN22 localization at the membrane is 
compromised, regulation of integrin signals is uncoupled, and both integrin clustering and cell 
adhesion are enhanced.  
 
Discussion 
Protein tyrosine phosphatases are now established as key regulators of integrin signaling (11, 
12). Indeed, the PTP-PEST family of phosphatases, which comprises PTPN12 as well as 
PTPN22, can be added to a growing list of negative regulators of integrin function that includes 
RhoH, DOK1, calpain and the ubiquitin ligase SHARPIN (28-31).  Single molecule localization 
microscopy has allowed us to image PTPN22 at the nanoscale level, and to document that 
membrane proximal declustering is linked both temporally and spatially to its inhibitory 
function. This is in contradistinction to the opposing clustering behaviour reported previously for 
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kinase associated signaling modules (32, 33), which has been shown to digitize signaling and 
increase signal transduction fidelity (34). Whether clustering in the steady state is unique to 
PTPN22, or a common mechanism for sequestering phosphatases from their substrates will 
require further study. 
 
The negative regulatory functions of native PTPN22 were confirmed by gene targeting in mouse 
and human T-cells. We also found that a catalytically active phosphatase was required to 
regulate integrin dependent cell motility. Experiments using PTPN22-W620 expressing T-cells 
from homozygous donors indicated that the disease-associated variant was a loss-of-function 
mutant, at least in the context of LFA-1 signaling. The basis for this functional difference is 
underpinned in part by impaired binding of the mutated P1 polyproline domain of PTPN22 with 
SH3 domain containing proteins, notably Csk. The spatiotemporal dynamics of PTPN22-Csk 
interactions and the impact of disrupting these associations on PTPN22 function are complex, 
and may be signal specific. For example, Vang and colleagues demonstrated that dissociation of 
PTPN22 from Csk is a prerequisite for targeting of the phosphatase to plasma membrane lipid 
raft domains where it attenuates T-cell receptor (TCR) signaling (35). PTPN22-W620 partitioned 
into rafts more efficiently, while forced dissociation of PTPN22 from Csk using a Csk-SH3 
domain also reduced TCR signals. These data support the gain-of-function hypothesis with 
respect to the W620 variant and TCR signaling, and suggest that the impact of the disease 
associated mutant is context dependent. While uncoupling of the PTPN22-W620-Csk association 
seems a consistent feature relevant to TCR and integrin dependent signaling (36, 37), we cannot 
rule out the possibility that disrupting interactions between PTPN22 and other SH3 domain 
containing proteins could contribute to the signaling phenotypes reported. A comparative 
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biochemical analysis of the PTPN22-R620 and W620 interactomes, using technologies recently 
reported for PAG would provide a systematic and unbiased approach to address this issue (38).  
 
We present a model depicting how PTPN22 regulates LFA-1 signaling and how expression of 
the PTPN22-W620 mutant enhances LFA-1 signaling and integrin-dependent adhesion (Fig. 7). 
According to this model, PTPN22 exists in large clusters in the steady state, sequestered from its 
substrates. De-clustering is triggered by active signals – an event we are now studying in the 
context of TCR as well as LFA-1 stimulation – and one that targets clustered pools of both 
PTPN22 and Csk. Precisely how the clusters disaggregate is not known, but the process serves to 
deliver monomers of PTPN22 to the membrane zone permitting interactions with its binding 
partners.  Lck is constitutively associated with the  chain of LFA-1 (17), and is required for 
recruitment of PTPN22 to the LFA-1 adhesome. In phosphatase deficient cells, LFA-1 induced 
phosphorylation of these intermediates goes unchecked, manifesting as hyper-phosphorylation of 
signaling intermediates and augmented integrin dependent signaling, cell motility and adhesion.  
The outcome of expressing PTPN22-W620 is the same, except that in this case total cellular 
levels of phosphatase are equivalent to those in R620 expressing T-cells, but the W620 variant 
fails to bind Csk (or other SH3 domain containing proteins).  Instead, PTPN22-W620 is 
distributed throughout the rest of the cell rather than being retained in the vicinity of the 
adhesome. Failure to attenuate LFA-1 signals is associated with much larger, denser clusters of 
LFA-1 at the cell surface, equipping the cell with domains of increased adhesiveness.   
 
How might increased cell adhesiveness translate to altered cell function in vivo? We suspect that 
the consequences of increased adhesion under shear flow conditions could perturb multiple 
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phases of lymph node and tissue homing, including adhesion of cells on vascular endothelium 
coupled to transmigration into tissues, trafficking across high endothelial venules within 
lymphoid organs, and interactions between cells or with the surrounding extracellular matrix. 
Integrins have other functions besides adhesion and migration, since they promote interactions 
between T-cells and antigen presenting cells in ways that underpin the earliest steps in T-cell 
activation and differentiation (9, 39), as well as downstream effector responses, such as cytokine 
expression and cytotoxic functions (4-6). We propose that aberrations of integrin function be 
included in the repertoire of mechanisms underpinning predisposition to autoimmune disease in 
individuals carrying loss-of-function PTPN22 mutations (40).  Loss of immune tolerance, 
however, will depend on the balance of function between effector and regulatory T-cells, since 
our work has previously demonstrated that increased adhesiveness of Ptpn22 deficient Tregs is 
in fact associated with greater potency (41). 
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MATERIALS AND METHODS 
 
Antibodies and integrin ligands  
Primary antibodies: Mouse monoclonal antibody (Ab) and affinity-purified goat polyclonal Ab, 
both raised against human PTPN22, were purchased from R&D Systems.  Antibodies to Vav1 
(C-14), ZAP-70 (1E7.2), Lck (3A5), Csk (C20), were from Santa Cruz Biotechnology. Rabbit 
polyclonal antibodies: p-Src (Tyr416), p-ZAP70 (Tyr319/SykTyr352), p-ZAP70 (Tyr493/Syk-
Tyr526), p-Erk (Thr202/Tyr204) (197G2), α/β-tubulin, β-actin (Cell Signalling Technology), p-
Vav1(Tyr174) (EP5107) (Abcam), and anti-PAG (PAG-C1) and anti-CD11a (LFA-1). mAb38 
was a kind gift of Dr Nancy Hogg. Secondary antibodies for immunoblotting detection: Sheep 
anti-mouse IgG-HRP (Amersham), goat anti-rabbit Ig-HRP (DAKO), mouse monoclonal light 
chain specific anti-goat IgG (Jackson Laboratory), goat anti-mouse IgG, goat anti-rabbit IgG, 
donkey anti-mouse IgG, donkey anti-rabbit IgG, donkey anti-goat IgG, and IgG1, IgG2b 
Zenon® antibody labelling kits were all from Life Technologies. Integrin ligands: Recombinant 
human ICAM-1/CD54 Fc chimera, recombinant murine ICAM-1/CD54 Fc chimera, recombinant 
VCAM-1 and fibronectin (R&D Systems).  
 
Mice  
Ptpn22 deficient mice were generated and genotyped for use in experiments as described (41). 
The line was re-derived into the Biological Services Unit at King’s College London and bred on 
a C57BL/6 background for 10 generations in SPF conditions, in compliance with Home Office 
regulations and local ethically approved guidelines. Sex and age matched Ptpn22+/+ and Ptpn22-/- 
littermates were used in experiments.   
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Media, cell culture and transfection  
Human T-cell complete medium: IMDM, 10% FBS, penicillin-streptomycin.  Murine T-cell 
complete medium: Glutamax-RPMI, 10% FBS, 50 μM βME, 100 μM sodium pyruvate, 20 mM 
HEPES, penicillin-streptomycin. Cell migration medium: Glutamax-RPMI, 50 μM βME, 100 
μM sodium pyruvate, 25 mM HEPES, penicillin-streptomycin. Peripheral blood mononuclear 
cells (PBMC) were isolated from whole blood using Lymphoprep (Stemcell Technologies) and 
phytohaemagglutinin (PHA) (ThermoScientific) in IMDM media 
supplemented with 10% FCS and penicillin-streptomycin (PAA) for the first 48 hours and 
supplemented with 20 ng/mL of IL-2 (Aldesleukin, Novartis) for up to 10 days. T-cells were 
purified using a pan T-cell isolation kit (cat no. 130-091-156, Miltenyi Biotec) to a purity of > 
97%, determined by flow cytometry.  Donors belonging to TwinsUK (www.twinsuk.ac.uk), and 
selected on the basis of their rs2476601 genotype (PTPN22 C1858T, corresponding to PTPN22-
R620W protein), also provided PBMC samples after informed consent.  Transfection of primary 
human T-cell blasts was achieved using the Amaxa Nucleofector and human T-cell 
Nucleofection Kit, programme T-020 (Lonza). Plasmid DNA (2 µg) and siRNA pools 
(Invitrogen, Thermo Fisher Scientific) were used to transfect 107 T-cells. Murine T-cells were 
generated from splenic and lymph node cell suspensions, adjusted to 3 x 106 cells/ml, and 
cultured in complete medium. Cells were stimulated with 1 μg/ml concanavalin A (ConA, 
Sigma) for 48 hours, subjected to a Ficoll gradient and re-suspended in complete medium 
supplemented with 20 ng/ml of IL-2 at a density of 2 x 106 cells/ml.  All adhesion and migration 
assays were conducted with murine T-cells after culture for 4-5 days in IL-2. The human 
leukemic T cell line, Jurkat, and its Lck-deficient derivative JCaM1.6, were also used in 
experiments (42). 
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Generation of PTPN22-GFP constructs 
A pEF5HA plasmid encoding PTPN22 (a kind gift from Dr Nunzio Bottini, La Jolla Institute for 
Allergy and Immunology, California, USA) was sequenced and used as a plasmid backbone for 
site directed mutagenesis to generate a panel of PTPN22 mutants; a 3’ GFP fragment was 
introduced by sub-cloning.  All constructs were verified by sequencing. Targeted mutations were 
introduced using the following specific primers pairs:   
R620W-Fwd (CCACTTCC TGTATGGACACCTGAATCATTTA) and 
R620W-Rev (TAAATGATTCAGGTGTCCATACAGGAAGTGG) 
C227A-Fwd (TGTTCCCATATGCATTCACGCCAGTGCTGGCTGTGGAAGGACTGG) and 
C227A-Rev (CCAGTCCTTCCACAGCCAGCACTGGCGTGAATGCATATGGGAACA 
 
T-cell stimulation and signaling with integrin ligands  
32 mm glass coverslips (VWR International) were coated in 6-well sterile plates with integrin 
ligands ICAM-1-Fc (3 µg/ml, unless indicated otherwise), VCAM-1-Fc (3 µg/ml), fibronectin 
(10 µg/ml) or poly-L-lysine (PLL; Sigma) overnight at 4°C, washed 3X with PBS and blocked 
for 1 hour at room temperature with 2% BSA in PBS.  Blasting T-cells were rested in medium 
for 30 min, then added to coverslips (3x106/coverslip) and incubated for 20 min at 37°C. After 
20 min unbound cells were aspirated and 1 ml of lysis buffer added to coverslips (1x 6-well 
plate; 2x107 cells) prior to lysis on ice for 20 min. Lysates were cleared by centrifugation and 
diluted in sample buffer for immunoblotting or immunoprecipitation experiments. 
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Immunoblotting and immunoprecipitation 
Cells were lysed directly in 2X SDS-PAGE sample buffer or in lysis buffer containing 1% Triton 
X-100 from Sigma, containing phosphatase and protease inhibitors (Roche). Proteins were 
separated by SDS-PAGE and transferred to immobilon-P polyvinylidene difluoride membranes 
by standard immunoblotting techniques. After incubation with primary and secondary antibodies, 
blots were visualised by SuperSignal chemiluminescent reaction (Pierce Biotechnology) in a 
Chemidoc Station (BioRad).  For immunoprecipitation, 1-2 µg of control or specific antibody 
was added to lysates overnight at 4°C followed by the addition of 20 µl magnetic beads 
(Millipore) for 1 hour at 4°C. Beads were washed 3X in lysis buffer prior to elution with 20 µl 
boiling 2X SDS-PAGE sample buffer.  Lysates and immunoprecipitates were used immediately, 
or stored at -80°C until analysis. 
 
Immunofluorescence staining and microscopy 
Coverslips, glass bottom dishes (Mattek) or 8-well glass bottomed microscopy chambers (Ibidi) 
were coated overnight at 4°C with human recombinant ICAM-1-Fc (3 µg/ml) or 0.01% Poly-L-
Lysine (PLL), washed 3X in HBSS and blocked in 5% BSA for 1 hour. T-cells were resuspended 
at 2.5x105 cells/ml in migration medium (HBSS, 10mM HEPES equilibrated overnight in 
incubator conditions) and added to ICAM-1-Fc coated glass.  After 20 min of migration cells 
were pH shift fixed (3% PFA-kPIPES 80 mM pH6.8 for 5 min supplemented with 2mM Mg2+ 
and 5mM EGTA followed by 3%-PFA Borax 100 mM pH11 for 10 min.) and permeabilised 
using 0.1% Triton at 4°C for 5 min. Autofluorescence was quenched using 1 mg/ml NaBH4 for 
15 min.  Chambers were blocked with 10% goat serum for 1 hour followed by incubation with 
primary antibody overnight and appropriate secondary antibody for 20 min. at room temperature. 
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Confocal microscopy was performed with a Zeiss LSM700 Axioimager M2 system at 63X 
magnification (Zeiss, Plan-Apochromat 63x/1.40 Oil M27, zoom 4, 512x512 pixel scan). TIRF 
images were obtained with Zeiss observer Z1 (inverted) microscope equipped with TIRF slider 
(Zeiss, Plan-Apochromat, 100X/1.40 Oil DIC (UV) VIS-IR). Images were collected, processed 
and analysed using Slidebook 5.5 (3i) or ImageJ software. Colocalization of signaling proteins 
was determined according to the method of Dunn and colleagues (43).  Briefly, TIRF images 
were processed with the automatic method of local background subtraction by median filtering 
and finally by small value subtraction using SlideBook6 software. Four regions (1.6 x 1.6 m) 
were chosen in the front lamella of the cell. Subsequently, Manders’ colocalization coefficient 
(MCC) was calculated with the inbuilt SlideBook6 function. Results from five regions were 
averaged per cell in four different experiments and analysed using Prism 6 Graphpad software. 
 
Stochastic Optical Reconstruction microscopy (dSTORM) 
dSTORM imaging was performed on a Nikon N-STORM microscope using a 100X 1.46N.A. oil 
immersion TIRF objective. Cells were imaged under TIRF illumination with a 647 nm laser with 
photo-activation at 405 nm in oxygen scavenging buffer (including 50 µg/ml glucose oxidase, 25 
µg/ml horseradish peroxidase and 75 mM cysteamine in base buffer, pH8.0).  Fluorescence was 
collected on an Andor iXon EM-CCD camera. Acquisition time was between 5 and 15 min with 
an integration time of 10 ms. Molecular coordinates were calculated by Nikon NIS N-STORM 
software using a photon threshold of 3000 per point spread function.   
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Cluster analysis 
The output from the NIS software is in the form of pointillist x-y coordinates of the localized 
fluorophores. Data were divided into non-overlapping 2 x 2 m square regions, avoiding cell 
boundaries. Ripley’s K-function can be used to quantify the level and size scale of molecular 
clustering and has previously been demonstrated in T-cells (44-46). The K-function is calculated 
for each region with the Excel plugin SpPack (45), using the equation: 
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Where ij=1 if the distance between molecules i and j is less than r, and is otherwise 0. Therefore 
ij represents drawing concentric circles of radius r around each point, i, and counting how many 
other points, j, are encircled. As defined, the K(r) value scales linearly with the circle area for 
increasing r and is therefore converted into the L-function using: 
/)()( rKrL   
This function is represented by a plot of L(r)-r versus r. In the case of a completely spatially 
random (CSR) distribution of molecules, L(r)-r = zero for all r. If L(r)-r is positive, this 
represents clustering on a particular spatial scale, r. Negative L(r)-r represents a more regular 
distribution than CSR (negative clustering). Edge effects are corrected by means of a toroidal 
wrap. 95% confidence intervals are calculated by simulating 100 CSR distributions with the 
same total molecular density as the experimental data. In order to test the effect of reducing the 
density of monomers (i.e. the CSR background) on the Ripley’s K-function curves we analysed 
simulated data. A 3 x 3 µm region was simulated with a single Gaussian profile cluster at its 
centre (s.d. = 100 nm, 100 points) that was then overlaid with a CSR background. We then 
varied the density of the CSR overlay and analysed the resulting Ripley’s K-function curves. In 
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the presence of zero background, the curve will decay linearly to negative infinity at increasing r, 
however in the presence of increasing background, the curve will asymptotically approach zero 
(as is the case for a pure CSR distribution).  To generate the pseudo-coloured cluster maps, the 
degree of clustering of each molecule is calculated using Getis’s variant of Ripley’s K-function 
(48). This is simply the L(r) value, omitting averaging over all molecule in the region (j). For 
each molecule, i, therefore, this value is given by: 
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Molecules at the edge of the region of interest have their L(r) corrected using a buffer region of 
width r. To generate the cluster maps, the L(r) values are interpolated onto a 5 nm resolution grid 
using Matlab and the L(r) colour surface pseudo-coloured. To extract cluster statistics, the map is 
thresholded at a value of L(r)=200, with areas above this value considered to be clusters. Clusters 
were separated using an 8-connectivity rule allowing us to extract the number of clusters, cluster 
sizes, number of molecules per cluster and other parameters. 
 
Flow cytometry 
T-cell blasts were stained in cold FACS buffer (0.5% BSA, 0.01% sodium azide) with antibodies 
and live/dead discrimination, washed, fixed with 2% PFA and analysed using a FACSCalibur. 
Data analysis was performed using FlowJo software (Treestar Incorporated). 
 
Time-lapse microscopy; attachment under shear flow 
Glass bottomed flow chambers (μ-slide VI0.4, ibidi) were coated with ICAM-1-Fc (5 μg/ml) and 
T-cell blasts (1 x 106 cells/ml) were flowed over glass at 0.5 dyn/cm² for 8-10 min in migration 
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media. Wide-field time-lapse movies were acquired in 10 areas per slide. Cell numbers were 
counted over time and data presented as mean ± SD values. 
 
Time-lapse microscopy; detachment under shear flow 
T-cells generated from Ptpn22+/+ and Ptpn22-/- mice (5 x 106 cells/ml) in migration media, 
allowed to adhere to ICAM-1-Fc (5 μg/ml) coated glass bottomed flow chambers (μ-slideVI0.1, 
ibidi) for 10 min and migration media (incubator equilibrated overnight) applied at shear flow 
rates from 5dyn/cm2 to 30dyn/cm2. Wide-field time-lapse images were acquired for 10 min and 
cell counts accrued every minute. Data were plotted as cell number (Y0)/time(X0) and One 
Phase decay Y=(Y0-plateau)*exp(-K*X)+ plateau applied to calculate the phase decay half-life, 
a value representing the rate at which T-cells detach from the glass over time, where low values 
indicate increased detachment. 
 
Statistical analysis 
All analyses were performed using Prism 6.0 software (GraphPad, La Jolla, CA).  Distributions 
of data points and their variance were determined and parametric or non-parametric tests applied, 
as appropriate.  Comparisons between two groups were evaluated using Mann Whitney U test; 
unpaired Student’s t tests were used for normally distributed data. Comparison of 3 or more 
independent conditions was determined using the rank based non-parametric Kruskall-Wallis H 
test, or Tukey’s Ordinary One-Way ANOVA multiple comparisons test for normally distributed 
data. For cell motility, cell adhesion and clustering data comparisons between groups were 
determined using unpaired two-tailed t tests. Student’s t tests were also applied to compare 
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densitometric measurements between independent immunoblotting experiments. Differences 
were considered significant when P<0.05. 
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Supplementary Materials 
 
Fig. S1. PTPN22 and its phosphosubstrates localize to the leading edge of migrating T-cells. 
 
Fig. S2. TIRF microscopy confirms colocalization of PTPN22 with its phosphorylated substrates. 
 
Fig. S3. Integrin engagement leads to inducible phosphorylation of PTPN22 substrates in 
migrating T-cells. 
 
Fig. S4. Csk declusters on LFA-1 engagement and associates with PTPN22 in migrating T-cells.   
 
Fig. S5. Cluster characteristics and expression of PTPN22-R620 and W620 in migrating T-cells. 
 
Fig. S6. PTPN22 associates with LFA-1 in an Lck-dependent manner. 
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FIGURES LEGENDS  
   
Fig. 1. PTPN22 is a negative regulator of LFA-1 signaling, co-localizing with its 
phosphorylated substrates at the leading edge of migrating T-cells. (A) Primary human T-
cell blasts were layered onto glass slides coated with poly-L-lysine (PLL) or ICAM-1 prior to 
staining with mouse anti-PTPN22 and the indicated anti-phosphospecific antibodies, and imaged 
by confocal microscopy. The direction of migration is indicated (large white arrows). Scale bars 
10 μm. Data represent analysis of 30-40 cells from 4 independent experiments. (B) Mouse anti-
PTPN22 or control IgG immunoprecipitates were generated from T-cells layered onto PLL or 
ICAM-1 coated plates for the indicated time, prior to immunoblotting with anti-phosphospecific 
antibodies; anti-PTPN22 (goat polyclonal), anti-Lck and anti-ZAP-70 blots were used to evaluate 
levels of total protein. (C) T-cells were transfected with scrambled (Scram) or specific (PTPN22) 
siRNA and cultured for a further 48 hours prior to plating onto PLL or ICAM-1.  After 20 min 
adherent cells were harvested and lysates resolved by SDS-PAGE prior to immunoblotting with 
the indicated antibodies. Blots were probed with goat anti-PTPN22 to confirm PTPN22 
depletion, and with anti-tubulin antibodies to control for protein loading. (D) T-cell blasts were 
transfected with scrambled siRNA (Scram) or PTPN22 specific siRNA and cultured for 24 hours 
prior to plating onto ICAM-1.  Migration of single cells was tracked by time-lapse microscopy.  
Dot plots show mean speeds (± SD) of T-cells for each siRNA condition; **** P<0.0001. (E) T 
cells were mock transfected (no DNA), or transfected with the indicated GFP expression vectors 
and velocity of cells quantified as for (D); ns – not significant, **** P<0.0001. (F) Murine T-
cells were generated from lymph nodes of Ptpn22+/+ or Ptpn22-/- littermates and allowed to 
migrate for 20 min on PLL or ICAM-1 coated plates. Lysates from adherent cells were probed 
with anti-phospho-ERK antibodies, or anti-ERK to control for protein loading. Fold changes in 
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expression relative to phospho-ERK in non-migrating (PLL) cells are shown (n = 3); * P=0.042. 
(G) Human T-cell blasts were generated from genotyped donors expressing PTPN22-R620 (RR), 
PTPN22-R620W (RW) or PTPN22-W620 (WW) and allowed to migrate on PLL or ICAM-1 
coated plates for 20 mins. Lysates were probed for phospho-ERK and total ERK expression. 
Fold changes relative to phospho-ERK in non-migrating (PLL) cells are shown (right panel; n = 
8 per genotype). Pairwise comparisons (two-tailed t test): RR/RW *P=0.0337; RW/WW 
*P=0.0144; RR/WW **P=0.0093. 
 
Fig. 2. PTPN22 exists in large clusters which disperse upon LFA-1 engagement. (A) Primary 
T-cell blasts were generated from peripheral blood of PTPN22-R620 homozygous donors and 
layered onto PLL or ICAM-1 coated plates for 20 min. prior to fixing, permeabilisation and 
staining with mouse anti-PTPN22 antibodies.  Images were acquired using a Nikon N-STORM 
microscope and molecule distributions analysed using cluster analysis algorithms.  For each 
condition N-STORM images are representative of PTPN22 molecule distributions at the whole 
cell level and 1 μm2 region maps, selected from the migrating T-cell leading edge. Pointillist 
(Gaussian fitted) and pseudo-coloured heat maps are representative of cluster data acquired after 
processing of N-STORM image-regions using the cluster analysis algorithm. Scale bars, 5 μm for 
PLL and 10 μm for ICAM-1 images. Data are representative of multiple experiments. (B) Cluster 
analysis of images was used to define the diameter of PTPN22-R620 clusters, and (C) the number 
of localizations per cluster, for >900 clusters in non-migrating (PLL) and migrating cells (ICAM-
1); **** P<0.0001.  (D) Ripley’s K-function curves (mean ± SEM) were generated to quantify 
the degree of clustering for non-migrating (PLL, solid line) and migrating T-cells (ICAM-1, 
dashed line) expressing PTPN22-R620.  
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Fig. 3. Retention of PTPN22-W620 at the membrane is impaired.  Primary T-cell blasts were 
generated from peripheral blood of PTPN22-R620 and W620 homozygous donors and layered 
onto PLL or ICAM-1 coated plates for 20 min. prior to fixing, permeabilisation and staining with 
mouse anti-PTPN22 antibodies. N-STORM images were acquired as described for Fig. 2, and 
cluster analysis used to define (A) the number of PTPN22-R620 and W620 clusters per region 
(n=126 regions), (B) the percentage of PTPN22 localizations in clusters (n=126 clusters) and (C) 
the number of PTPN22 localizations per region (n=126 regions). Bars represent mean values ± 
SD; * P<0.02, **** P<0.0001, ns – not significant. (D) Pointillist (Gaussian fitted) and pseudo-
coloured heat maps are representative of cluster data acquired after processing of N-STORM 
image-regions, as described for Fig. 2A. Scale bars, 5 μm for PLL and 10 μm for ICAM-1. (E) 
Ripley’s K-function curves (mean ± SEM) were constructed to quantify the degree of clustering 
of PTPN22-R620 (dashed line) and PTPN22-W620 (solid line) in T-cells migrating on ICAM-1.  
Data are representative of three independent experiments. (F) Csk immunoprecipitates were 
generated from non-migrating (PLL) or migrating (ICAM-1) T-cells expressing PTPN22-R620 
(RR) or W620 (WW) derived from homozygous donors, and probed with goat anti-PTPN22 
antibodies, or anti-Csk to control for protein loading.  Quantification of PTPN22/Csk association 
relative to PLL for 3 independent experiments is shown (right panel). Bars represent mean values; 
Tukey’s Ordinary One-Way Anova multiple comparisons test *** P<0.0005, ** P<0.005, ns – 
not significant. 
 
Fig. 4. PTPN22 colocalizes with LFA-1 at the leading edge of migrating T-cells.  (A) T-cells 
migrating on ICAM-1 were stained with antibodies to PTPN22 (goat polyclonal) and LFA-1 
(mab38) and imaged by (A) confocal microscopy, or (B) TIRF microscopy. PTPN22 (green) and 
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LFA-1 (red) co-localize at the leading edge. Direction of migration is shown (white arrows). In 
B, higher magnification shows co-localization of PTPN22 and LFA-1 (panel B merge, small 
white arrows). Bright field images with intensity scales for PTPN22 and LFA-1 stained cells are 
also shown (right panels). Data are representative of regions selected from the leading edge of 
30-40 cells in 4 independent experiments. (C) Expression of LFA-1 and PTPN22 in anti-LFA-1 
or IgG control immunoprecipitates derived from non-migrating (PLL) and migrating (ICAM-1) 
T-cells was determined by immunoblotting. (D) Jurkat T-cells and their JCam1.6 Lck-deficient 
derivative were plated onto PLL for 20 min. Cell lysates were prepared and probed with 
antibodies to Lck and ZAP-70 (upper panel). Mouse anti-PTPN22 immunoprecipitates were 
generated from both Jurkat lines and probed with antibodies to PTPN22 (goat) and LFA-1 (lower 
panel). 
 
Fig. 5. Expression of the PTPN22-W620 variant enhances LFA-1 clustering at the leading 
edge of migrating T-cells.  (A) T-cells from homozygous donors expressing PTPN22-R620 or 
PTPN22-W620 were layered onto PLL or ICAM-1 coated plates for 20 min. prior to fixing and 
staining with anti-LFA-1. Images were acquired and molecule distributions analysed as 
described in Figure 2. For each PTPN22 variant representative images are shown for cell surface 
LFA-1 molecule distributions.  Single regions were used to generate pointillist and pseudo-
coloured cluster heat maps. Scale bar 5 μm. (B) Ripley’s K-function curves (mean ± SEM) were 
constructed to quantify the degree of clustering of surface LFA-1 in PTPN22-R620 (dashed line) 
and PTPN22-W620 (solid line) expressing T-cells migrating on ICAM-1. Data are representative 
of three independent experiments. (C) Cluster analysis of N-STORM images derived from 
PTPN22-R620 and PTPN22-W620 expressing T-cells migrating on ICAM-1 was used to 
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quantify the number of LFA-1 localizations per region (n = 83 regions), (D) number of LFA-1 
clusters (n = 83 regions), and (E) the % of LFA-1 localizations in clusters (n = 83 clusters). Data 
represent mean values ± SD. ns – not significant, **** P<0.0001. 
 
Fig. 6. T-cells expressing loss-of-function/expression PTPN22 mutants are more adherent 
under shear-flow. (A) PTPN22-R620 and PTPN22-W620 expressing T-cells derived from 
homozygous donors were flowed over glass slides coated with ICAM-1 (5 μg/ml) at a shear flow 
rate of 0.5dyn/cm2 and imaged by time-lapse wide-field microscopy. Cells adhering to ICAM-1 
coated glass were counted every minute for total of 8 min. Pooled data for each genotype are 
derived from 12 independent experiments; * P=0.049. (B) T-cells were generated from the 
lymph nodes of Ptpn22+/+ and Ptpn22-/- littermates and adherence under flow quantified as 
described for (A). A representative experiment (left), and pooled data (right) show the mean 
number of adherent cells (± SD) after 10 min. for each genotype, based on 6 independent 
experiments; ** P=0.002. (C) Murine T-cells were prepared as described for (B) and allowed to 
adhere to ICAM-1 (5μg/ml) coated glass slides for 10 min.  Shear force was applied at the 
indicated flow rates, and time-lapse wide-field movies acquired. Numbers of adherent T-cells 
were counted every minute for 10 min. Phase decay analysis generated half-life values for cell 
attachment over time. Data represent 11 independent experiments; ns – not significant, * 
P=0.0472,  ** P=0.005. *** P=0.0008.  
 
Fig. 7. Mechanistic model for regulation of integrin signaling by PTPN22.  The transition 
from a low or intermediate LFA-1 affinity state (middle panel) to a high affinity state (left panel) 
is characterized by phosphorylation of Lck, ZAP-70 and Vav associated with the 2 chain 
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cytoplasmic tail of LFA-1.  Subsequently, spatiotemporal regulation of LFA-1 signals is 
mediated by dispersal of PTPN22 and Csk from clusters, disassociation of PTPN22 and Csk 
from PAG at the membrane, and increased association of PTPN22 with Csk through the P1 
domain of PTPN22 and SH3 domain of Csk. PTPN22-Csk complexes target phosphorylated 
substrates in the LFA-1 adhesome, leading to attenuation of LFA-1 signaling.  While 
declustering of the loss-of-function PTPN22-W620 mutant is preserved, binding of PTPN22-
W620 to Csk is impaired (right panel). The mutant phosphatase is not retained at the membrane, 
and in the absence of membrane proximal binding partners, such as Csk, PTPN22-W620 diffuses 
away from the membrane. As a consequence, LFA-1 signal intensity is augmented and sustained, 
further promoting LFA-1 clustering at the cell surface and increasing integrin-dependent 
adhesion (right panel).  The spatiotemporal organization of PTPN22-R620 (PTP), PTPN22-
W620 (PTP-W), Csk (Csk), talin (Tal), Lck, Vav1 (Vav), ZAP-70 (Zap) and Kindlin are 
illustrated. P – denotes phosphorylation on tyrosine residues. 
 
 
 
 
 
